Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Valcyte Supplemental Approval Extends Treatment Time

August 11, 2010 7:27 am | News | Comments

Genentech, Inc. announced that the U.S. Food and Drug Administration approved increasing the length of therapy with Valcyte in adult kidney transplant patients at high risk for cytomegalovirus disease.


Immunomedics Granted Second CD74 Patent

August 11, 2010 7:24 am | News | Comments

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, announced that a second patent has been granted for the CD74 target, stengthening the company's protection.


Shire Grants Noven Daytrana Marketing Rights

August 11, 2010 7:19 am | News | Comments

Shire plc, the global specialty biopharmaceutical company, announced the divestiture of Daytrana to Noven Pharmaceuticals, Inc. Daytrana is approved and marketed in the US for the treatment of attention deficit hyperactivity disorder in children and adolescents.


Alpharadin In Trial to Treat Bone Metastases

August 11, 2010 7:09 am | News | Comments

Algeta ASA, the focused oncology company, announces that it has treated the first patient in a phase 1/2a trial of Alpharadin in combination with docetaxel. The trial aims to recruit up to 60 men with bone metastases resulting from castration-resistant prostate cancer.


Marinomed Antiviral Spray Effective Against Colds

August 11, 2010 6:58 am | News | Comments

Marinomed Biotechnologie GmbH announced that a pilot clinical trial examining the company’s antiviral nasal spray, which contains carrageenan, was effective as a treatment against the common cold.


HemaQuest Begins Trial of EBV-Related Cancer Drug

August 11, 2010 6:53 am | News | Comments

HemaQuest Pharmaceuticals announced that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus infection.


Cell Culture Dish

August 10, 2010 8:39 am | Product Releases | Comments

Thermo Fisher Scientific Inc. has introduced BioLite products for general cell culture applications. Manufactured from a US Pharmacopeia class VI polystyrene resin, BioLite products are sterile and non-pyrogenic, making the culture surfaces suitable for many standard cell lines.


Pre-Capped Storage Tubes

August 10, 2010 8:27 am | Product Releases | Comments

Pre-capped sample storage tubes from Micronic Europe are manufactured under US Federal standard 209E Class 7 cleanroom conditions to ensure cleanliness and sterility.


RTS Announces New US Headquarters

August 10, 2010 8:09 am | News | Comments

RTS Life Science, a worldwide supplier of automated sample management and pharmaceutical testing systems, has announced their new US headquarters and the formation of "RTS Life Science LLC".


VS110 Wins Two Awards At Scanner Competition

August 10, 2010 8:05 am | News | Comments

Olympus recently earned two awards at the first European Scanner Contest, which took place in Berlin in conjunction with the 94th Annual Meeting of the German Society of Pathology and the 10th Pathology Federal Meeting.


Scientists Map Interactions of Human Genes

August 10, 2010 7:53 am | News | Comments

In one of the first efforts of its kind, researchers have taken mammalian genome maps, including human maps, one step further by showing not just the order in which genes fall in the genome but which genes actually interact.


Fighting Prostate Cancer Without Harming The Body

August 10, 2010 7:48 am | News | Comments

A kinase is a type of enzyme the body uses to regulate the functions of the proteins required for cell growth and maintenance, and researchers have discovered that one in particular plays a key role in developing prostate cancer.


Amarin Triglyceride-Lowering Drug in Phase 3 Trial

August 10, 2010 7:42 am | News | Comments

Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, announced that its MARINE trial, a Phase 3 clinical trial of AMR101, has completed patient enrollment and randomization into the treatment phase of this trial.


Vertex HCV Drug Could Shorten Treatment Time

August 10, 2010 7:37 am | News | Comments

Vertex Pharmaceuticals Inc. said that a study showed some patients who take its hepatitis C drug candidate telaprevir may be able to complete their treatment sooner.


Nanomachines Useful For Cancer Drug Delivery

August 10, 2010 7:05 am | News | Comments

Scientists from UCLA's California NanoSystems Institute and Korea's Yonsei University have developed an innovative method that enables nanomachines to release drugs inside living cancer cells when activated remotely by an oscillating magnetic field.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.